Virus-Based Therapy Boosts Anti-Cancer Immune Responses to Brain Cancer
February 11, 2026
February 11, 2026
BOSTON, Massachusetts, Feb. 11 [Category: BizHospital] -- Mass General Brigham issued the following news release:
* * *
Virus-Based Therapy Boosts Anti-Cancer Immune Responses to Brain Cancer
*
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus-a genetically modified virus that selectively infects and destroys cancer cells-can recruit immune cells to penet . . .
* * *
Virus-Based Therapy Boosts Anti-Cancer Immune Responses to Brain Cancer
*
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus-a genetically modified virus that selectively infects and destroys cancer cells-can recruit immune cells to penet . . .